{"transactions":[{"id":1913251,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-26T20:50:00.000Z","date":"2022-12-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/18/2022."}],"balance_after":186722,"source":{"system":"sec-edgar","filing":"0001251371-23-000002","document":"wf-form4_168255658655192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000125137123000002/wf-form4_168255658655192.xml","form_type":"4"}},{"id":1915525,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-04-21T20:48:32.000Z","date":"2023-04-19","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity\nIncentive Plan (the \"Plan\")) and accelerated on the closing of a Change of Control (as defined in the Plan)."}],"balance_after":18000,"derivative":{"exercise_price":1.82,"expiration_date":"2033-04-18","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-23-025286","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919123025286/doc4.xml","form_type":"4"}},{"id":2229672,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-16T21:14:12.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the \"Plan\")) and accelerated on the closing of a Change of Control (as defined in the Plan)."}],"balance_after":15750,"derivative":{"exercise_price":1.3,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-22-037672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919122037672/doc4.xml","form_type":"4"}},{"id":2251046,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T08:55:25.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":141000,"price":0.3525,"value":49702.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions and the price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":236722,"source":{"system":"sec-edgar","filing":"0001618835-22-000130","document":"wf-form4_165400171064865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883522000130/wf-form4_165400171064865.xml","form_type":"4"}},{"id":2377865,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-02-23T16:04:48.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 18, 2022."}],"balance_after":750000,"derivative":{"exercise_price":0.49,"expiration_date":"2032-02-18","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001618835-22-000028","document":"wf-form4_164565026543618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883522000028/wf-form4_164565026543618.xml","form_type":"4"}},{"id":2377864,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-23T16:04:48.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2022."}],"balance_after":1435837,"source":{"system":"sec-edgar","filing":"0001618835-22-000028","document":"wf-form4_164565026543618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883522000028/wf-form4_164565026543618.xml","form_type":"4"}},{"id":2447979,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-04T16:03:56.000Z","date":"2021-12-31","kind":"disposition_to_issuer","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/3/2021."}],"balance_after":685837,"source":{"system":"sec-edgar","filing":"0001618835-22-000004","document":"wf-form4_164133021790367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883522000004/wf-form4_164133021790367.xml","form_type":"4"}},{"id":2463648,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-20T16:19:18.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":135000,"price":0.375,"value":50625.0,"ownership":{"direct":true},"balance_after":985837,"source":{"system":"sec-edgar","filing":"0001618835-21-000271","document":"wf-form4_164003514607858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000271/wf-form4_164003514607858.xml","form_type":"4"}},{"id":2623690,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-27T06:00:28.000Z","date":"2021-07-26","kind":"purchase","acquired":true,"shares":6545,"price":3.82,"value":25001.9,"ownership":{"direct":true},"balance_after":12045,"source":{"system":"sec-edgar","filing":"0001209191-21-048272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919121048272/doc4.xml","form_type":"4"}},{"id":2655676,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-24T19:01:15.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders."}],"balance_after":10500,"derivative":{"exercise_price":6.55,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-21-043141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919121043141/doc4.xml","form_type":"4"}},{"id":2673598,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-10T19:30:07.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":50000,"price":1.03,"value":51500.0,"ownership":{"direct":true},"balance_after":850837,"source":{"system":"sec-edgar","filing":"0001618835-21-000147","document":"wf-form4_162336778417446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000147/wf-form4_162336778417446.xml","form_type":"4"}},{"id":2700543,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-21T16:25:34.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":105300,"price":0.86,"value":90558.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction."}],"balance_after":800837,"source":{"system":"sec-edgar","filing":"0001618835-21-000133","document":"wf-form4_162162870730649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000133/wf-form4_162162870730649.xml","form_type":"4"}},{"id":2799433,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-09T18:59:38.000Z","date":"2021-03-09","kind":"purchase","acquired":true,"shares":45249,"price":2.28,"value":103167.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":906137,"source":{"system":"sec-edgar","filing":"0001618835-21-000052","document":"wf-form4_161533435338287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000052/wf-form4_161533435338287.xml","form_type":"4"}},{"id":2881104,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-02-03T20:05:03.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021."}],"balance_after":700000,"derivative":{"exercise_price":3.25,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001618835-21-000015","document":"wf-form4_161240068137959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000015/wf-form4_161240068137959.xml","form_type":"4"}},{"id":2881103,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T20:05:03.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021."}],"balance_after":860888,"source":{"system":"sec-edgar","filing":"0001618835-21-000015","document":"wf-form4_161240068137959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883521000015/wf-form4_161240068137959.xml","form_type":"4"}},{"id":3034196,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-10T20:04:39.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":122500,"price":3.26,"value":399350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.09 to $3.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total amount of securities beneficially owned includes 4,303 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period."}],"balance_after":360888,"source":{"system":"sec-edgar","filing":"0001618835-20-000218","document":"wf-form4_159978266397349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000218/wf-form4_159978266397349.xml","form_type":"4"}},{"id":3108641,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-16T17:24:05.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders."}],"balance_after":4500,"derivative":{"exercise_price":2.07,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-20-037018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919120037018/doc4.xml","form_type":"4"}},{"id":3108640,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T17:24:05.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":3000,"price":2.0697,"value":6209.1,"ownership":{"direct":true},"balance_after":5500,"source":{"system":"sec-edgar","filing":"0001209191-20-037018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919120037018/doc4.xml","form_type":"4"}},{"id":3108639,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T17:24:05.000Z","date":"2020-06-11","kind":"purchase","acquired":true,"shares":2500,"price":2,"value":5000.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-20-037018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919120037018/doc4.xml","form_type":"4"}},{"id":3118326,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-08T17:42:38.000Z","date":"2020-06-05","kind":"tax_withholding","acquired":false,"shares":85620,"price":3.31,"value":283402.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 5, 2020. No shares were sold in connection with this transaction."}],"balance_after":479085,"source":{"system":"sec-edgar","filing":"0001618835-20-000187","document":"wf-form4_159165254089208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000187/wf-form4_159165254089208.xml","form_type":"4"}},{"id":3134876,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-05-26T17:17:15.000Z","date":"2020-05-22","kind":"tax_withholding","acquired":false,"shares":84525,"price":4.99,"value":421779.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":564705,"source":{"system":"sec-edgar","filing":"0001618835-20-000159","document":"wf-form4_159052781756168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000159/wf-form4_159052781756168.xml","form_type":"4"}},{"id":3156100,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-05-08T12:31:11.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":16905,"price":5.24,"value":88582.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction."}],"balance_after":649230,"source":{"system":"sec-edgar","filing":"0001618835-20-000112","document":"wf-form4_158895545390049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000112/wf-form4_158895545390049.xml","form_type":"4"}},{"id":3202103,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-18T16:29:27.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable in three equal annual installments commencing on the first anniversary of the grant date set forth in column 3 above."}],"balance_after":6000,"derivative":{"exercise_price":1.12,"expiration_date":"2030-03-15","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-20-020002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919120020002/doc4.xml","form_type":"4"}},{"id":3284231,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-02-07T16:33:30.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 5, 2020."}],"balance_after":300000,"derivative":{"exercise_price":4.87,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001618835-20-000022","document":"wf-form4_158111119257424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000022/wf-form4_158111119257424.xml","form_type":"4"}},{"id":3284230,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-07T16:33:30.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2020."}],"balance_after":666135,"source":{"system":"sec-edgar","filing":"0001618835-20-000022","document":"wf-form4_158111119257424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000022/wf-form4_158111119257424.xml","form_type":"4"}},{"id":3284229,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-07T16:33:30.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":3846,"price":5.21,"value":20037.66,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Evofem Biosciences, Inc. 2019 Employee Stock Purchase Plan (2019 ESPP), for the ESPP purchase period of June 17, 2019 through December 13,2019. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F2","text":"The reporting person is voluntarily reporting this transaction as of February 5, 2020, but the actual transaction took place on December 13, 2019, the last trading day of the purchase period under the 2019 ESPP."},{"field":"shares","element":"transactionShares","label":"F3","text":"In accordance with the 2019 ESPP, these shares were purchased based on 85% of the closing stock price on December 13, 2019, the last trading day of the purchase period."}],"balance_after":366135,"source":{"system":"sec-edgar","filing":"0001618835-20-000022","document":"wf-form4_158111119257424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000022/wf-form4_158111119257424.xml","form_type":"4"}},{"id":3310743,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-15T16:22:12.000Z","date":"2020-01-13","kind":"sale","acquired":false,"shares":3295,"price":6,"value":19770.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2019."}],"balance_after":362289,"source":{"system":"sec-edgar","filing":"0001618835-20-000010","document":"wf-form4_157912331106987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000010/wf-form4_157912331106987.xml","form_type":"4"}},{"id":3317834,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-06T15:08:18.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":6705,"price":6.05,"value":40565.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":365584,"source":{"system":"sec-edgar","filing":"0001618835-20-000004","document":"wf-form4_157834128185451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883520000004/wf-form4_157834128185451.xml","form_type":"4"}},{"id":3352314,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-12-04T17:33:23.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":20000,"price":7.3,"value":146000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.26 to $7.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":372289,"source":{"system":"sec-edgar","filing":"0001618835-19-000212","document":"wf-form4_157549878641244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883519000212/wf-form4_157549878641244.xml","form_type":"4"}},{"id":3358556,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-11-26T17:15:47.000Z","date":"2019-11-25","kind":"tax_withholding","acquired":false,"shares":22387,"price":6.22,"value":139247.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 25, 2019. No shares were sold in connection with this transaction."}],"balance_after":392289,"source":{"system":"sec-edgar","filing":"0001618835-19-000205","document":"wf-form4_157480653003211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883519000205/wf-form4_157480653003211.xml","form_type":"4"}},{"id":3362811,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-11-21T20:18:28.000Z","date":"2019-11-21","kind":"sale","acquired":false,"shares":10000,"price":6.01,"value":60100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":414676,"source":{"system":"sec-edgar","filing":"0001618835-19-000184","document":"wf-form4_157438549248266.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883519000184/wf-form4_157438549248266.xml","form_type":"4"}},{"id":3362810,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-11-21T20:18:28.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":22657,"price":5.74,"value":130051.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 20, 2019. No shares were sold in connection with this transaction."}],"balance_after":424676,"source":{"system":"sec-edgar","filing":"0001618835-19-000184","document":"wf-form4_157438549248266.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883519000184/wf-form4_157438549248266.xml","form_type":"4"}},{"id":3429101,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-26T18:37:29.000Z","date":"2019-08-22","kind":"tax_withholding","acquired":false,"shares":4923,"price":5.13,"value":25254.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on August 22, 2019. No shares were sold in connection with this transaction."}],"balance_after":447333,"source":{"system":"sec-edgar","filing":"0001618835-19-000157","document":"wf-form4_156685903031279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883519000157/wf-form4_156685903031279.xml","form_type":"4"}},{"id":3492433,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-12T16:38:50.000Z","date":"2019-06-10","kind":"tax_withholding","acquired":false,"shares":35826,"price":6.36,"value":227853.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 10, 2019. No shares were sold in connection with this transaction."}],"balance_after":452256,"source":{"system":"sec-edgar","filing":"0001618835-19-000124","document":"wf-form4_156037191603901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883519000124/wf-form4_156037191603901.xml","form_type":"4"}},{"id":3564115,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-03T18:39:08.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":3731,"price":3.55,"value":13245.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on April 1, 2019. No shares were sold in connection with this transaction."}],"balance_after":488082,"source":{"system":"sec-edgar","filing":"0001618835-19-000045","document":"wf-form4_155433113300126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883519000045/wf-form4_155433113300126.xml","form_type":"4"}},{"id":3628679,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-02-27T16:11:09.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2019."}],"balance_after":491813,"source":{"system":"sec-edgar","filing":"0001618835-19-000020","document":"wf-form4_155130185570707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883519000020/wf-form4_155130185570707.xml","form_type":"4"}},{"id":3745632,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-12-03T12:50:30.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":284625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on November 29, 2018, is being amended to update the number of shares reported in Column 5(A) and Column 7 of Table II."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from November 28, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4, filed on November 29, 2018, is being amended to update the number of shares reported in Column 5(A) and Column 7 of Table II."}],"balance_after":284625,"derivative":{"exercise_price":3.45,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":284625},"source":{"system":"sec-edgar","filing":"0001618835-18-000127","document":"wf-form4a_154385941410060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883518000127/wf-form4a_154385941410060.xml","form_type":"4/A","original_submission_date":"2018-11-29"}},{"id":3748691,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-11-29T18:09:37.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from November 28, 2018."}],"balance_after":284625,"derivative":{"exercise_price":3.45,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001618835-18-000115","document":"wf-form4_154353296123716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883518000115/wf-form4_154353296123716.xml","form_type":"4"}},{"id":3845982,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-13T18:48:27.000Z","date":"2018-08-10","kind":"purchase","acquired":true,"shares":10000,"price":2.11,"value":21100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.11 to $2.12, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":341813,"source":{"system":"sec-edgar","filing":"0001618835-18-000083","document":"wf-form4_153420048493947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883518000083/wf-form4_153420048493947.xml","form_type":"4"}},{"id":3854815,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-08-02T16:20:04.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from July 31, 2018."}],"balance_after":313500,"derivative":{"exercise_price":2.1,"expiration_date":"2028-07-31","underlying":"Common Stock","underlying_shares":313500},"source":{"system":"sec-edgar","filing":"0001618835-18-000075","document":"wf-form4_153324118436415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883518000075/wf-form4_153324118436415.xml","form_type":"4"}},{"id":3874359,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-07-03T16:58:13.000Z","date":"2018-07-02","kind":"tax_withholding","acquired":false,"shares":493187,"price":2.46,"value":1213240.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on July 2, 2018. No shares were sold in connection with this transaction."}],"balance_after":331813,"source":{"system":"sec-edgar","filing":"0001618835-18-000048","document":"wf-form4_153065147716261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883518000048/wf-form4_153065147716261.xml","form_type":"4"}},{"id":3874358,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-07-03T16:58:13.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards vested in full on July 2, 2018."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001618835-18-000048","document":"wf-form4_153065147716261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000161883518000048/wf-form4_153065147716261.xml","form_type":"4"}},{"id":3996079,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-03-14T20:13:27.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Ms. Pelletier acquired a vested interest in 66.67% of the shares of common stock exercisable pursuant to the option effective as of March 12, 2018 (the \"Vesting Start Date\"). The remaining shares shall vest in a series of twelve (12) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from the Vesting Commencement Date. The option was awarded in connection with Ms. Pelletier's service as President and Chief Executive Officer."}],"balance_after":825000,"derivative":{"exercise_price":7.29,"expiration_date":"2028-03-12","underlying":"Common Stock","underlying_shares":825000},"source":{"system":"sec-edgar","filing":"0001209191-18-019687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919118019687/doc4.xml","form_type":"4"}},{"id":4095863,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-18T17:07:15.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":6719,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 17, 2018, Issuer completed a merger transaction (the \"Merger\") pursuant to an Agreement and Plan of Merger and Reorganization, dated October 17, 2017, by and among Issuer, Nobelli Merger Sub, Inc., and Evofem Biosciences Operations, Inc., formerly known as Evofem Biosciences, Inc. (\"Evofem Operations\"), as filed with the Securities and Exchange Commission on Form 8-K on October 17, 2017 (the \"Merger Agreement\"). Pursuant to the Merger Agreement all issued and outstanding options of Evofem Operations converted into and became options to purchase shares of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Ms. Pelletier acquired a vested interest in one hundred percent (100%) of the shares of common stock exercisable pursuant to the option effective as of June 3, 2013."}],"balance_after":6719,"derivative":{"exercise_price":79.87,"expiration_date":"2023-06-03","underlying":"Common Stock","underlying_shares":6719},"source":{"system":"sec-edgar","filing":"0001209191-18-004307","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919118004307/doc4.xml","form_type":"4"}},{"id":4095862,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-18T17:07:15.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":9994,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 17, 2018, Issuer completed a merger transaction (the \"Merger\") pursuant to an Agreement and Plan of Merger and Reorganization, dated October 17, 2017, by and among Issuer, Nobelli Merger Sub, Inc., and Evofem Biosciences Operations, Inc., formerly known as Evofem Biosciences, Inc. (\"Evofem Operations\"), as filed with the Securities and Exchange Commission on Form 8-K on October 17, 2017 (the \"Merger Agreement\"). Pursuant to the Merger Agreement all issued and outstanding options of Evofem Operations converted into and became options to purchase shares of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Ms. Pelletier acquired a vested interest in one hundred percent (100%) of the shares of common stock exercisable pursuant to the option effective as of September 28, 2016."}],"balance_after":9994,"derivative":{"exercise_price":46.36,"expiration_date":"2026-09-28","underlying":"Common Stock","underlying_shares":9994},"source":{"system":"sec-edgar","filing":"0001209191-18-004307","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919118004307/doc4.xml","form_type":"4"}},{"id":4095861,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-18T17:07:15.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":12833,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 17, 2018, Issuer completed a merger transaction (the \"Merger\") pursuant to an Agreement and Plan of Merger and Reorganization, dated October 17, 2017, by and among Issuer, Nobelli Merger Sub, Inc., and Evofem Biosciences Operations, Inc., formerly known as Evofem Biosciences, Inc. (\"Evofem Operations\"), as filed with the Securities and Exchange Commission on Form 8-K on October 17, 2017 (the \"Merger Agreement\"). Pursuant to the Merger Agreement all issued and outstanding options of Evofem Operations converted into and became options to purchase shares of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Ms. Pelletier acquired a vested interest in twenty-five percent (25%) of the shares of common stock exercisable pursuant to the option effective as of September 28, 2017 (the \"Vesting Start Date\"). The remaining shares shall vest in a series of thirty-six (36) successive equal monthly installments on the monthly anniversary of the Vesting Start Date, such that all shares of common stock of Issuer exercisable pursuant to the option shall be fully vested on September 28, 2020, subject to Ms. Pelletier's continued service."}],"balance_after":12833,"derivative":{"exercise_price":46.36,"expiration_date":"2026-09-28","underlying":"Common Stock","underlying_shares":12833},"source":{"system":"sec-edgar","filing":"0001209191-18-004307","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919118004307/doc4.xml","form_type":"4"}},{"id":4095860,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":78731,"kind":"person","name":"PELLETIER SAUNDRA L","position":1,"cik":"0001251371","reported_name":"PELLETIER SAUNDRA L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-18T17:07:15.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":19249,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 17, 2018, Issuer completed a merger transaction (the \"Merger\") pursuant to an Agreement and Plan of Merger and Reorganization, dated October 17, 2017, by and among Issuer, Nobelli Merger Sub, Inc., and Evofem Biosciences Operations, Inc., formerly known as Evofem Biosciences, Inc. (\"Evofem Operations\"), as filed with the Securities and Exchange Commission on Form 8-K on October 17, 2017 (the \"Merger Agreement\"). Pursuant to the Merger Agreement all issued and outstanding options of Evofem Operations converted into and became options to purchase shares of Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options to purchase common stock of Issuer were received in connection with the Merger in exchange for options to purchase shares of common stock of Evofem Operations. Each option to purchase one share of common stock of Evofem Operations was cancelled and exchanged for the right to receive an option to purchase 0.154 shares of common stock of Issuer. The shares of common stock of Issuer exercisable pursuant to the option reported reflect any necessary adjustments to account for the 6 for 1 reverse stock split effected by Issuer on January 17, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Ms. Pelletier acquired a vested interest in twenty-five percent (25%) of the shares of common stock exercisable pursuant to the option effective as of September 28, 2016 (the \"Vesting Start Date\"). The remaining shares shall vest in a series of thirty-six (36) successive equal monthly installments on the monthly anniversary of the Vesting Start Date, such that all shares of common stock of Issuer exercisable pursuant to the option shall be fully vested on September 28, 2019, subject to Ms. Pelletier's continued service."}],"balance_after":19249,"derivative":{"exercise_price":46.36,"expiration_date":"2026-09-28","underlying":"Common Stock","underlying_shares":19249},"source":{"system":"sec-edgar","filing":"0001209191-18-004307","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251371/000120919118004307/doc4.xml","form_type":"4"}}]}